All In Biotech

Drug Trial Radar · NCT04146051

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)

Last checked: Nov 20, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Dec 4, 2019

Primary completion

Jan 5, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Cartesian TherapeuticsIndustry
Sponsor type
Industry
First posted
Oct 31, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase IIb study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis

Conditions

  • Myasthenia Gravis, Generalized

Interventions

  • Descartes-08Drug

    Autogolous T-cells expressing a chimeric antigen receptor directed to BCMA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients with MG Composite improvement of ≥5 points.Time frame: Day 0 to Day 85

Locations

15 sites in 2 countries. Site status is shown where the registry gives one.

  • Profound Research

    Carlsbad, California

  • University of California Irvine

    Irvine, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • SFM Clinical Research, LLC

    Boca Raton, Florida

  • Neurology Associates, P.A.

    Orlando, Florida

  • University of South Florida

    Tampa, Florida

  • University of Augusta

    Augusta, Georgia

  • University of Kansas Medical Center Research Institute

    Kansas City, Kansas

  • Dent Neurologic Institute

    Amherst, New York

  • University of North Carolina

    Chapel Hill, North Carolina

  • Oregon Health & Science University

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Allegheny Health Network

    Pittsburgh, Pennsylvania

  • Virginia Commonwealth University

    Richmond, Virginia

  • University of Alberta

    Edmonton, Alberta, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.